Cite
High exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population‐based cohort study.
MLA
Tsai, Shin‐Chia, et al. “High Exposure Compared with Standard Exposure to Metoclopramide Associated with a Higher Risk of Parkinsonism: A Nationwide Population‐based Cohort Study.” British Journal of Clinical Pharmacology, vol. 84, no. 9, Sept. 2018, pp. 2000–09. EBSCOhost, https://doi.org/10.1111/bcp.13630.
APA
Tsai, S., Sheu, S., Chien, L., Lee, H., Yuan, E. J., & Yuan, R. (2018). High exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population‐based cohort study. British Journal of Clinical Pharmacology, 84(9), 2000–2009. https://doi.org/10.1111/bcp.13630
Chicago
Tsai, Shin‐Chia, Shiow‐Yunn Sheu, Li‐Nien Chien, Hsin‐Chien Lee, Eunice Jia‐Shiow Yuan, and Rey‐Yue Yuan. 2018. “High Exposure Compared with Standard Exposure to Metoclopramide Associated with a Higher Risk of Parkinsonism: A Nationwide Population‐based Cohort Study.” British Journal of Clinical Pharmacology 84 (9): 2000–2009. doi:10.1111/bcp.13630.